85 related articles for article (PubMed ID: 20573400)
1. Glycosylation interference on RhoA activation: focus on G-CSF.
Mattii L; Battolla B; Azzarà A; D'Urso G; Montali U; Petrini M
Leuk Res; 2011 Feb; 35(2):265-7. PubMed ID: 20573400
[TBL] [Abstract][Full Text] [Related]
2. Glycosylated or non-glycosylated G-CSF differently influence human granulocyte functions through RhoA.
Mattii L; Azzarà A; Fazzi R; Carulli G; Chimenti M; Cecconi N; Galimberti S; Petrini M
Leuk Res; 2005 Nov; 29(11):1285-92. PubMed ID: 15916805
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation of recombinant human granulocyte colony stimulating factor: implications for stability and potency.
Nissen C
Eur J Cancer; 1994; 30A Suppl 3():S12-4. PubMed ID: 7535065
[TBL] [Abstract][Full Text] [Related]
4. Effects of glycosylated and non-glycosylated G-CSFs, alone and in combination with other cytokines, on the growth of human progenitor cells.
Pedrazzoli P; Gibelli N; Pavesi L; Preti P; Piolini M; Bertolini F; Robustelli della Cuna G
Anticancer Res; 1996; 16(4A):1781-5. PubMed ID: 8712701
[TBL] [Abstract][Full Text] [Related]
5. Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor.
Carulli G; Mattii L; Azzarà A; Brizzi S; Galimberti S; Zucca A; Benedetti E; Petrini M
Am J Hematol; 2006 May; 81(5):318-23. PubMed ID: 16628714
[TBL] [Abstract][Full Text] [Related]
6. Three types of recombinant human granulocyte colony-stimulating factor have equivalent biological activities in monkeys.
Tanaka H; Tanaka Y; Shinagawa K; Yamagishi Y; Ohtaki K; Asano K
Cytokine; 1997 May; 9(5):360-9. PubMed ID: 9195136
[TBL] [Abstract][Full Text] [Related]
7. Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)--what is the difference?
Höglund M
Med Oncol; 1998 Dec; 15(4):229-33. PubMed ID: 9951685
[TBL] [Abstract][Full Text] [Related]
8. Role of carbohydrate moiety in granulocyte colony stimulating factor.
Sakagami H; Tajima M; Takayama F; Oi T; Kusama K; Yamamoto T; Saito M; Murayama J
Anticancer Res; 2000; 20(4):2355-9. PubMed ID: 10953296
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical and biochemical characteristics of glycosylated recombinant human granulocyte colony stimulating factor (lenograstim).
Ono M
Eur J Cancer; 1994; 30A Suppl 3():S7-11. PubMed ID: 7535073
[TBL] [Abstract][Full Text] [Related]
10. Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF)--results of a prospective randomised monocentre study.
Bönig H; Silbermann S; Weller S; Kirschke R; Körholz D; Janssen G; Göbel U; Nürnberger W
Bone Marrow Transplant; 2001 Aug; 28(3):259-64. PubMed ID: 11535993
[TBL] [Abstract][Full Text] [Related]
11. Effect of glycosylation of recombinant human granulocytic colony-stimulating factor on expansion cultures of umbilical cord blood CD34+ cells.
Querol S; Cancelas JA; Amat L; Capmany G; Garcia J
Haematologica; 1999 Jun; 84(6):493-8. PubMed ID: 10366791
[TBL] [Abstract][Full Text] [Related]
12. Glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor differently modifies actin polymerization in neutrophils.
Zucca A; Brizzi S; Riccioni R; Azzarà A; Ghimenti M; Carulli G
Clin Ter; 2006; 157(1):19-24. PubMed ID: 16669548
[TBL] [Abstract][Full Text] [Related]
13. Differences in functional activity and antigen expression of granulocytes primed in vivo with filgrastim, lenograstim, or pegfilgrastim.
Ribeiro D; Veldwijk MR; Benner A; Laufs S; Wenz F; Ho AD; Fruehauf S
Transfusion; 2007 Jun; 47(6):969-80. PubMed ID: 17524085
[TBL] [Abstract][Full Text] [Related]
14. Superior mobilisation of haematopoietic progenitor cells with glycosylated G-CSF in male but not female unrelated stem cell donors.
Fischer JC; Frick M; Wassmuth R; Platz A; Punzel M; Wernet P
Br J Haematol; 2005 Sep; 130(5):740-6. PubMed ID: 16115131
[TBL] [Abstract][Full Text] [Related]
15. Harvesting peripheral blood progenitor cells from healthy donors: retrospective comparison of filgrastim and lenograstim.
Martino M; Console G; Irrera G; Callea I; Condemi A; Dattola A; Messina G; Pontari A; Pucci G; Furlò G; Bresolin G; Iacopino P; Morabito F
J Clin Apher; 2005 Oct; 20(3):129-36. PubMed ID: 15892086
[TBL] [Abstract][Full Text] [Related]
16. Lenograstim and filgrastim effects on neutrophil motility in patients undergoing chemotherapy: evaluation by computer-assisted image analysis.
Azzarà A; Carulli G; Rizzuti-Gullaci A; Capochiani E; Petrini M
Am J Hematol; 2001 Apr; 66(4):306-7. PubMed ID: 11279646
[No Abstract] [Full Text] [Related]
17. Comparison of lenograstim and filgrastim on haematological effects after autologous peripheral blood stem cell transplantation with high-dose chemotherapy.
Kim IH; Park SK; Suh OK; Oh JM
Curr Med Res Opin; 2003; 19(8):753-9. PubMed ID: 14687447
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
Carlsson G; Ahlin A; Dahllöf G; Elinder G; Henter JI; Palmblad J
Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
[TBL] [Abstract][Full Text] [Related]
19. Crossover study of the haematological effects and pharmacokinetics of glycosylated and non-glycosylated G-CSF in healthy volunteers.
Watts MJ; Addison I; Long SG; Hartley S; Warrington S; Boyce M; Linch DC
Br J Haematol; 1997 Aug; 98(2):474-9. PubMed ID: 9266953
[TBL] [Abstract][Full Text] [Related]
20. Mobilization of peripheral blood stem cells by granulocyte-colony stimulating factors: comparison of a standard dose of glycosylated and mutated granulocyte-colony stimulating factor in non-Hodgkin's lymphoma patients following CHOP therapy.
Takemoto Y; Wada H; Takatsuka H; Okamoto T; Kakishita E
Drugs Exp Clin Res; 2000; 26(1):1-5. PubMed ID: 10761530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
